Rilematovir
Rilematovir (JNJ-678) is a small molecule fusion inhibitor for researching Respiratory Syncytial Virus (RSV) treatment. It exhibits potent antiviral activity with low cytotoxicity, making it suitable for both in vitro antiviral assays and in vivo efficacy studies in animal models of RSV infection.
Product Specifications
CAS Number
1383450-81-4
Product Name Alternative
RSV, Rilematovir, JNJ 53718678, JNJ 678, JNJ678, JNJ-678, JNJ53718678, JNJ-53718678, Fusion protein
Field of Research
Cardiovascular Research, Infectious Disease & Virology, Signal Transduction
Purity
99.82% (May vary between batches)
Solubility
DMSO:58.5 mg/mL (116.79 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.99 mM)
Smiles
CS (=O) (=O) CCCn1c (Cn2c3cnccc3n (CC (F) (F) F) c2=O) cc2cc (Cl) ccc12
Molecular Formula
C21H20ClF3N4O3S
Molecular Weight
500.92
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-Mouse-ear cress EMB2423 Antibody HRP Conjugated
KCNJ1 (ROMK1, ATP-sensitive inward rectifier potassium channel 1, ATP-regulated potassium channel ROM-K, Inward rectifier K (+) channel Kir1.1, Potassium channel, inwardly rectifying subfamily J member 1) (FITC)